American Herbal Products Association (AHPA) > Resources > Regulations > Government Advocacy

Recent AHPA Advocacy

AHPA joins dietary supplement industry to urge swift congressional action on CBD

Congress urged to pass legislation to clarify that CBD derived from hemp is a lawful dietary ingredient

This week, the four leading trade associations representing the U.S. dietary supplement industry joined forces to urge Congress to take action to ensure consumer safety and provide legal clarity in the cannabidiol (CBD) product marketplace. In a letter, the American Herbal Products Association (AHPA), Consumer Healthcare Products Association (CHPA), Council for Responsible Nutrition (CRN), and United Natural Products Alliance (UNPA) called on Congress “to pass legislation to clarify that CBD derived from the hemp plant is a lawful dietary ingredient if the dietary supplement containing the CBD meets established product safety and quality criteria.”

Food & Beverage Issue Alliance requests FDA enforcement discretion for new nutrition labeling rule

AHPA joins 12 leading trade associations to request FDA enforcement discretion

AHPA joined 12 leading trade associations to advocate FDA to provide flexibility in its enforcement of the new nutrition labeling rules as the January 1, 2020 compliance date approaches. In a letter to Acting FDA Commissioner Dr. Ned Sharpless, the associations, acting as the Food & Beverage Issue Alliance, requested FDA to to provide a six-month period of enforcement discretion following the compliance date.

AHPA presents at the AOAC INTERNATIONAL 133rd Annual Meeting & Exposition

Michael McGuffin and Holly Johnson, Ph.D. outline ways AOAC analytical methods can support the herbal supplement industry

AHPA President Michael McGuffin and Chief Science Officer Holly Johnson, Ph.D. presented at the AOAC International 133rd Annual Meeting and Exposition to help the organization further develop analytical methods for botanicals used in herbal supplements.
Dietary supplement recalls are relatively infrequent according to recent FDA data

Dietary supplement recalls are relatively infrequent according to recent FDA data

Two percent of more than 800 recalls initiated in 2019 involved dietary supplement products

Recall data from the Food and Drug Administration (FDA) shows that 14 of 803 (1.7 percent) recorded recalls initiated in 2019 involved dietary supplements, and among these, three were Class I recalls (the most serious recall class), according to an article published in the August 2019 AHPA Report.
CO Gov Jared Polis charts course for CBD and hemp innovation at sold-out AHPA Supplement Congress

CO Gov Jared Polis charts course for CBD and hemp innovation at sold-out AHPA Supplement Congress

USDA and FDA officials share key information for companies selling hemp-CBD in dietary supplements

Colorado Governor Jared Polis rallied more than 200 hemp farmers, manufacturers, producers, retailers, and industry professionals during his keynote address to the American Herbal Products Association (AHPA) Hemp-CBD (cannabidiol) Supplement Congress held earlier this month.
Ginseng program at 2020 Smithsonian Folklife Festival

Ginseng program at 2020 Smithsonian Folklife Festival

June 24-28 and July 1-5, 2020 -- Washington, DC

The AHPA Foundation for Education and Research on Botanicals (AHPA ERB Foundation) has committed to provide financial support for the American ginseng program to be presented as part of the 2020 Smithsonian Folklife Festival, an annual 10-day event that takes place on the National Mall in Washington, D.C. The Foundation is seeking matching funds from AHPA members to increase the Foundation’s support of this program.
Michael McGuffin Celebrates 20 years as AHPA President

Michael McGuffin Celebrates 20 years as AHPA President

An Open Letter to the Membership

It is my heartfelt honor to address you today on the 20th anniversary of the date I began my role as President of the American Herbal Products Association. We have accomplished so much together since 1999!

AHPA urges FDA to protect consumers by quickly clarifying hemp-CBD regulations

Existing supplement and food regulations are sufficiently robust for hemp-derived ingredients

The American Herbal Products Association (AHPA) urged the Food and Drug Administration (FDA) last week to protect consumers by quickly taking specific actions to clarify the regulatory status of hemp and hemp-derived ingredients used in dietary supplements and foods that contain cannabidiol (CBD).
IADSA update on international supplement regulations

IADSA update on international supplement regulations

IADSA July 2019 Newsflash

China considers adding 5 functional ingredients, including reishi powder and spirulina, to its food raw materials directory, and changes to permitted health food function claims, in this issue of the IADSA Newsflash.

AHPA recommends FDA implement policies to support innovation

The American Herbal Products Association (AHPA) submitted extensive and specific policy recommendations on July 15 to the Food and Drug Administration (FDA) to support responsible dietary supplement innovation while preserving and strengthening FDA’s ability to efficiently and effectively protect the public from unsafe and unlawful products.
RSS
12345678910 Last

2020 Annual Fund Sponsors

   

AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.